Equities analysts forecast that Henry Schein Inc (NASDAQ:HSIC) will post earnings per share of $1.01 for the current fiscal quarter, Zacks reports. Ten analysts have provided estimates for Henry Schein’s earnings. The highest EPS estimate is $1.03 and the lowest is $0.97. Henry Schein posted earnings of $0.88 per share in the same quarter last year, which would suggest a positive year over year growth rate of 14.8%. The business is expected to issue its next earnings results on Tuesday, August 14th.
According to Zacks, analysts expect that Henry Schein will report full-year earnings of $4.10 per share for the current financial year, with EPS estimates ranging from $4.05 to $4.15. For the next fiscal year, analysts forecast that the firm will post earnings of $4.44 per share, with EPS estimates ranging from $4.10 to $4.54. Zacks’ EPS averages are an average based on a survey of sell-side research firms that follow Henry Schein.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 8th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.92 by $0.03. The business had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.18 billion. Henry Schein had a return on equity of 19.68% and a net margin of 3.18%. The company’s revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.88 EPS.
A number of equities research analysts recently weighed in on the company. ValuEngine cut Henry Schein from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 2nd. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Tuesday, April 24th. Northcoast Research set a $102.00 price target on Henry Schein and gave the stock a “buy” rating in a report on Tuesday, April 24th. Deutsche Bank upped their price target on Henry Schein from $79.00 to $82.00 and gave the stock a “buy” rating in a report on Tuesday, April 24th. Finally, Goldman Sachs cut Henry Schein from a “buy” rating to a “neutral” rating in a report on Tuesday, April 24th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $81.59.
A number of hedge funds have recently bought and sold shares of HSIC. Generation Investment Management LLP lifted its stake in shares of Henry Schein by 561.1% during the 4th quarter. Generation Investment Management LLP now owns 11,026,174 shares of the company’s stock worth $770,509,000 after purchasing an additional 9,358,345 shares during the period. Select Equity Group L.P. lifted its stake in shares of Henry Schein by 68.2% during the 1st quarter. Select Equity Group L.P. now owns 6,476,540 shares of the company’s stock worth $435,288,000 after purchasing an additional 2,625,408 shares during the period. Mackenzie Financial Corp lifted its stake in shares of Henry Schein by 53.0% during the 4th quarter. Mackenzie Financial Corp now owns 6,023,557 shares of the company’s stock worth $420,926,000 after purchasing an additional 2,085,324 shares during the period. Deutsche Bank AG lifted its stake in shares of Henry Schein by 300.6% during the 4th quarter. Deutsche Bank AG now owns 1,560,951 shares of the company’s stock worth $109,076,000 after purchasing an additional 1,171,302 shares during the period. Finally, American Century Companies Inc. purchased a new position in shares of Henry Schein during the 4th quarter worth $67,346,000. 95.58% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HSIC traded down $0.16 on Tuesday, reaching $71.30. The stock had a trading volume of 857,400 shares, compared to its average volume of 1,859,688. The stock has a market cap of $11.08 billion, a P/E ratio of 19.84, a P/E/G ratio of 1.72 and a beta of 1.04. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.44 and a quick ratio of 0.74. Henry Schein has a twelve month low of $62.56 and a twelve month high of $93.50.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.